BioWorld Asia

May 12, 2004

View Archived Issues

Arpida Raises CHF51.3M, Plans To Move Iclaprim Into Phase III

Arpida Ltd. raised CHF51.3 million (US$39.4 million) in a Series C funding round, bringing its total funding to date to CHF105 million. (BioWorld International) Read More

Faust Pharmaceuticals Closes EUR16M Second-Round Financing

Read More

Molecular Switch That Triggers Apoptosis Delivers Drug Target

Read More

Eirx Out-Licenses Apoptosis Targets To OSI In $18.8M Deal

Read More

Lectus Gets Investment From Takeda For PFD Protein Work

Read More

Report: 25 Recommendations For EU Strategies On Genetic Testing

Read More

Immatics Raises EUR8.5M In First Round Of Financing

Read More

Advanced Biotherapy Cross-Licenses IP With Innogenetics

Read More

Biota Holdings Suing GSK Over Support For Flu Drug

Read More

Other News To Note

Read More